Tender detail
Pazopanib medicine discount agreements under an open-house model
Summary
The procurement concerns non-exclusive discount agreements for medicines containing the active ingredient pazopanib (ATC code L01EX03), concluded through an open-house model. The purchase volume is unknown and no minimum quantities are guaranteed; agreements end no later than 31 January 2029.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.